Precision Oncology · Molecular Profiling · Innovation

The future of oncologyis shaped by personalized treatments.

Modern oncology requires understanding the unique biology of every patient and every tumor. By bringing together clinical experience, molecular profiling, current scientific evidence, and innovative treatment options, my aim is to identify the right treatment strategy for each patient, at the right time.

Explore the clinical perspective Vision & profile

**Prof. Dr. Ahmet Dirican, MD, PhD**Medical Oncology

Personalized oncologyPatient and tumor biology together

Genomic profilingNGS, biomarkers, liquid biopsy and ctDNA

Clinical researchPhase II–III trial experience

InnovationThe right patient, at the right time

01 / Vision & Profile

Precision oncologyMolecular insightClinical value

From clinical need to clinical value

Looking at the future of oncology through real clinical needs. Using technology for people. Translating scientific innovation into clinical value.

Scientific progress is not simply a new data point or a new technology. The most important part is understanding how a development affects clinical decisions, for which patients it is meaningful, and what limitations it carries today.

“For me, the true value of innovation begins when it can change a patient’s treatment decision.”

CV / Academic & Scientific Profile

From clinical expertise to scientific innovation

My academic and clinical career has been shaped by a continuous commitment to integrating evidence-based oncology, scientific research, and emerging technologies into personalized cancer care. My work focuses on translating advances in molecular oncology and innovative therapeutics into meaningful clinical strategies for patients.

01Academic biography 02Education & career 03Selected publications 04Congresses and speaking

02 / Clinical Perspective

Personalized oncology: evaluate the patient and tumor biology together

Current scientific evidence and innovative treatment options, evaluated in the context of each patient.

Shape treatment decisions not only around the diagnosis, but also around the patient’s clinical characteristics, the biology of the tumor, and its molecular features.

Evaluate the patient and tumor biology together

Shape treatment decisions around both clinical characteristics and tumor biology.

Interpret scientific evidence in clinical context

Assess new evidence through the clinical benefit it may provide to the individual patient.

Personalize treatment

Consider biomarkers, molecular profiling and appropriate innovative options alongside standards.

Use innovation in the right patient, at the right time

Use new technologies when they can meaningfully contribute to the treatment journey.

Comprehensive genomic profiling (NGS)Biomarker-driven treatmentLiquid biopsy / ctDNATargeted therapiesImmunotherapyPersonalized cancer vaccinesMultidisciplinary evaluationClinical trials

03 / Looking Ahead

Scientific and technological fields shaping the future of oncology

The future of cancer care will be shaped by a deeper understanding of tumor biology, increasingly precise treatment strategies, and the intelligent integration of emerging technologies into clinical practice.